Prognostic value of nuclear maspin expression for adjuvant 5-fluorouracil-based chemotherapy in advanced gastric cancer

By            

Experimental and Therapeutic Medicine, Vol. 3, Iss. 6, 2012-01 ,pp. : 993-998

Spandidos Publications

Access to resources Recommend Favorite

Prediction of clinical outcome of fluoropyrimidine-based chemotherapy for gastric cancer patients, in terms of the 5-fluorouracil metabolic pathway

By Ichikawa Wataru  

Gastric Cancer, Vol. 9, Iss. 3, 2006-08 ,pp. : 145-155

Springer Publishing Company

Access to resources Recommend Favorite

Associations Between Genetic Polymorphisms of Epidermal Growth Factor Receptor (EGFR) and Survival of Colorectal Cancer (CRC) Patients Treated with 5-Fluorouracil-Based Chemotherapy

By Lai Ching-Yu   Sung Fung-Chang   Hsieh Ling-Ling   Tang Reiping   Chiou Hung-Yi   Wu Fang-Yang   Yeh Chih-Ching  

Annals of Surgical Oncology, Vol. 20, Iss. 3, 2013-12 ,pp. : 599-606

Springer Publishing Company

Access to resources Recommend Favorite

Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil–epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy

By Ohno S.   Chow L.   Sato N.   Masuda N.   Sasano H.   Takahashi F.   Bando H.   Iwata H.   Morimoto T.   Kamigaki S.   Nakayama T.   Nakamura S.   Kuroi K.   Aogi K.   Kashiwaba M.   Yamashita H.   Hisamatsu K.   Ito Y.   Yamamoto Y.   Ueno T.   Fakhrejahani E.   Yoshida N.   Toi M.  

Breast Cancer Research and Treatment, Vol. 142, Iss. 1, 2013-11 ,pp. : 69-80

Springer Publishing Company

Access to resources Recommend Favorite

Metabolomic analysis of dynamic response and drug resistance of gastric cancer cells to 5-fluorouracil

By              

Oncology Reports, Vol. 29, Iss. 3, 2013-01 ,pp. : 925-931

Spandidos Publications

Access to resources Recommend Favorite